Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04464174
Title Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer (PATHFINDER)
Acronym PATHFINDER
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Champalimaud Clinical Centre - Champalimaud Foundation Lisboa 1400-038 Portugal Details
Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto) Porto 4200-072 Portugal Details
Hospital Provincial de Castellón Castellón De La Plana Castellón 12002 Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca El Palmar Murcia 30120 Spain Details
Hospital del Mar Barcelona 08003 Spain Details
Hospital Universitari Dexeus Barcelona Spain Details
Hospital San Pedro de Alcántara Cáceres 10003 Spain Details
Hospital Universitari Arnau de Vilanova Lleida 25198 Spain Details
Hospital Quiron San Camilo- Ruber Juan Bravo Madrid 28006 Spain Details
Hospital Universitario Ramón y Cajal Madrid 28034 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
Hospital Clínico Universitario de Valencia Valencia 46010 Spain Details
Hospital Arnau de Vilanova Valencia 46015 Spain Details
Hospital Universitario Miguel Servet Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field